Published in J Gastroenterol Hepatol on November 01, 2007
Management of hemangioma of the liver: surgical therapy or observation? World J Surg (2013) 2.23
Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford) (2014) 1.05
Right trisegmentectomy with thoracoabdominal approach after transarterial embolization for giant hepatic hemangioma. World J Gastroenterol (2009) 1.05
Giant liver hemangioma resected by trisectorectomy after efficient volume reduction by transcatheter arterial embolization: a case report. J Med Case Rep (2010) 0.99
Resection of a rapid-growing 40-cm giant liver hemangioma. World J Hepatol (2010) 0.97
Laparoscopic resection of a giant exophytic liver haemangioma with the laparoscopic Habib 4× radiofrequency device. World J Gastrointest Surg (2012) 0.92
A case of a ruptured sclerosing liver hemangioma. Int J Hepatol (2011) 0.92
Successful liver resection in a giant hemangioma with intestinal obstruction after embolization. World J Gastroenterol (2013) 0.90
Liver resection for benign hepatic lesions: a retrospective analysis of 827 consecutive cases. World J Gastroenterol (2008) 0.88
Diagnosis and management of giant hepatic hemangioma: the usefulness of contrast-enhanced ultrasonography. Int J Hepatol (2013) 0.87
Surgical treatment of giant liver hemangiomas: enucleation with continuous occlusion of hepatic artery proper and intermittent Pringle maneuver. World J Surg (2010) 0.86
Cavernous hemangioma of the liver: factors affecting disease progression in general hepatology practice. Eur J Gastroenterol Hepatol (2011) 0.82
Feasibility of laparoscopic liver resection for giant hemangioma of greater than 6 cm in diameter. Korean J Hepatobiliary Pancreat Surg (2014) 0.78
Major hepatectomy for a symptomatic giant liver cavernous hemangioma. Hepatobiliary Surg Nutr (2015) 0.75
Orthotopic liver transplantation for giant liver haemangioma: A case report. World J Transplant (2015) 0.75
CT and MRI findings correlate with the time-course of unresectable cavernous haemangioma of the liver after fractionated radiotherapy. Br J Radiol (2012) 0.75
Resection for hepatic hemangiomas. J Gastroenterol Hepatol (2007) 0.75
Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med (2010) 10.21
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med (2002) 8.72
Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med (2007) 7.56
Effect of a comprehensive surgical safety system on patient outcomes. N Engl J Med (2010) 7.46
Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery (2007) 6.62
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol (2005) 4.91
Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery (2007) 4.72
Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med (2008) 4.33
Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest Endosc (2006) 3.60
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet (2011) 3.54
Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA (2007) 3.30
Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2012) 3.28
Cytological punctures in the diagnosis of renal tumours: a study on accuracy and reproducibility. Eur Urol (2008) 2.80
Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa. Ann Surg (2013) 2.79
Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol (2006) 2.72
The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut (2009) 2.72
Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology (2008) 2.54
Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial. Lancet (2002) 2.42
Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease. Gut (2006) 2.41
Liver adenomatosis: re-evaluation of aetiology and management. Liver Int (2008) 2.30
High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol (2010) 2.30
Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointest Endosc (2006) 2.22
Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg (2005) 2.21
Antecolic versus retrocolic route of the gastroenteric anastomosis after pancreatoduodenectomy: a randomized controlled trial. Ann Surg (2014) 2.15
Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial. Ann Surg (2012) 2.09
Delayed massive hemorrhage after pancreatic and biliary surgery: embolization or surgery? Ann Surg (2005) 2.06
Jejunal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol (2010) 2.03
Imaging of perihilar cholangiocarcinoma. AJR Am J Roentgenol (2015) 2.00
Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.98
Temporary closure of the open abdomen: a systematic review on delayed primary fascial closure in patients with an open abdomen. World J Surg (2009) 1.96
The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology (2011) 1.94
Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol (2005) 1.87
The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg (2003) 1.84
Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired. J Surg Oncol (2006) 1.82
TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.82
Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81
Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med (2007) 1.80
A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg (2002) 1.79
Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol (2006) 1.78
Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch (2005) 1.74
Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg (2008) 1.73
Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol (2006) 1.72
Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation. Liver Transpl (2007) 1.71
Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg (2010) 1.70
Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.70
Hyposplenism: comparison of different methods for determining splenic function. Am J Hematol (2012) 1.69
Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol (2007) 1.67
[Using the SETQ system to evaluate and improve teaching qualities of clinical teachers]. Ned Tijdschr Geneeskd (2010) 1.66
TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66
Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg (2007) 1.64
Initial experiences of an enhanced recovery protocol in esophageal surgery. World J Surg (2013) 1.63
High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology (2009) 1.62
Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg (2003) 1.62
Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg (2008) 1.60
Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc (2011) 1.60
Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.58
Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr (2005) 1.56
Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol (2007) 1.55
TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.53
The innate immune response to secondary peritonitis. Shock (2007) 1.52
Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model. Eur J Nucl Med Mol Imaging (2006) 1.50
New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.49
Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.49
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance. J Clin Gastroenterol (2009) 1.47
The presence and mucin histochemistry of cardiac type mucosa at the esophagogastric junction. Am J Gastroenterol (2004) 1.46
Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg (2009) 1.45
Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology (2010) 1.44
Quantitative electroencephalography in a swine model of cerebral arterial gas embolism. Clin Neurophysiol (2011) 1.44
Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.43
(99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med (2010) 1.42